New hope for liver cancer patients who have no other options
NCT ID NCT07377487
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study is testing a treatment called BSJ019T in Japanese patients with liver cancer that cannot be removed by surgery and has not responded to standard treatments. The goal is to see if the treatment can control the cancer's growth and how safe it is. About 51 participants will be enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER NEOPLASMS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hyogo College of Medicine Hospital
NOT_YET_RECRUITINGNishinomiya, Hyōgo, 663-8501, Japan
-
Kanazawa University Hospital
RECRUITINGKanazawa, Ishikawa-ken, 920-8641, Japan
-
Kindai University Hospital
NOT_YET_RECRUITINGSayama, Osaka, 589-8511, Japan
-
National Cancer Center Hospital
NOT_YET_RECRUITINGChuo Ku, Tokyo, 104-0045, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a tailored diet before surgery boost liver cancer recovery?
- Can a simple belly press make liver cancer radiation more precise?
- Can a Heat-and-Freeze treatment plus a vaccine outsmart pancreatic cancer?
- A new way to read CT scans may predict which liver surgery patients will develop Life-Threatening failure
- Can a cancer vaccine prime the body to better fight liver tumors?
- A drug used during liver surgery may cut the risk of major complications — a study puts it to the test